Advanced Search

Order Of 7 February 2003 Amending The List Of Pharmaceutical Specialties Approved Use Of

Original Language Title: Arrêté du 7 février 2003 modifiant la liste des spécialités pharmaceutiques agréées à l'usage des

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.

Text information




JORF No. 40 of 16 February 2003 Page 2823
Text No. 13


ARRETE
Order of February 7, 2003 Amending the List of Certified Pharmaceutical Specialties for the Use of Communities and Various Utilities

NOR: SANS0320428A ELI: http://www.legifrance.gouv.fr/eli/arrete/2003/2/7/SANS0320428A/jo/texte


The Minister of Health, Family and Disability Issues,
Given the Social Security Code;
Due to the Public Health Code;
Due to the general code of the Taxes, in particular Article 281 octies;
Having regard to Decree No. 82-253 of 16 March 1982 applying Articles L. 618 and L. 619 (L. 5123-2 and L. 5123-3) of the Public Health Code;
Seen in the opinion of the Transparency Commission,
Stops:

Item 1


List of Certified Pharmaceutical Specialties for Community Use and Various Utilities is Changed In accordance with the provisions set out in the Annex.

Article 2


The Director General of Health and the Director of Security Shall be responsible for the execution of this Order, which shall be published and its annex to the Official Journal of the French Republic.

Item Appendix


A N N E X E
FIRST PART
(23 entries)


The following pharmaceutical specialties are listed on the list of approved drugs: Use of communities and various utilities:


You can view the table in OJ
n ° 40, 16/02/2003 page 2823 to 2824



PART TWO
(2 Radiation)


The following pharmaceutical specialties are removed from the list of approved drugs for use by communities and various utilities:


You can view the table in OJ
n ° 40, 16/02/2003 page 2823 to 2824


Done at Paris, February 7, 2003.


For the Minister and by delegation :By preventing the Director

from Social Security:

The

subdirector of the

funding for the care system,

S. Seiller

By preventing

from the Director General of Health:

The

policy

policy for health products,

H. Sainte Marie


Download the document in RTF (weight < 1MB) Facsimile (format: pdf, weight < 3.5 MB) Download document to RDF (format: rdf, weight < 1MB)